Silicon Laboratories Inc. balance sheet

At the end of fiscal 2025, Silicon Laboratories Inc. had total assets of $1.27bn, total liabilities of $175m and shareholders' equity of $1.09bn. It held $364m in cash against $0 of debt: net cash of $364m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Silicon Laboratories Inc.: balance sheet, annual
Fiscal year	2009Jan 2010	2010Jan 2011	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Jan 2015	2015Jan 2016	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Jan 2021	2021Jan 2022	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Jan 2026	LTMJul 2026
Cash and equivalents	196	139	95	105	96	142	114	141	269	197	227	203	1,075	500	228	282	364	362
Receivables	56	45	55	78	72	70	74	74	71	73	76	95	98	71	29	54	65	80
Inventory	32	39	35	50	45	53	54	60	73	75	73	48	49	100	194	106	96	123
Total current assets	524	494	453	468	459	529	423	491	948	827	944	976	2,239	1,461	738	602	674	671
Goodwill	105	112	115	130	229	229	273	276	288	397	237	376	376	376	376	376	376	376
Total assets	743	728	706	872	991	1,043	1,011	1,082	1,535	1,624	1,675	1,993	2,958	2,169	1,443	1,223	1,269	1,253
Accounts payable	29	24	26	30	22	39	42	40	39	41	39	55	47	90	57	42	51	52
Total current liabilities	89	80	83	106	109	163	142	140	162	145	138	284	669	186	164	98	144	124
Short-term debt	—	—	—	5	8	10	10	—	—	—	—	—	—	—	—	—	—	—
Long-term debt	—	—	—	95	88	78	68	73	—	—	—	—	—	—	—	—	—	—
Total debt	0	0	0	100	95	88	78	73	342	355	368	563	—	530	—	0	0	0
Total liabilities	113	102	107	222	253	285	250	255	582	557	560	794	746	764	234	143	175	158
Shareholders' equity	630	625	599	650	739	758	761	827	953	1,067	1,115	1,200	2,212	1,405	1,209	1,080	1,094	1,095
Net debt (negative = net cash)	−196	−139	−95	−5	−1	−54	−37	−69	73	158	141	361	−1,075	30	−228	−282	−364	−362
Shares outstanding	46m	44m	42m	42m	43m	42m	42m	42m	43m	43m	43m	44m	38m	32m	32m	32m	33m	33m

US$ millions unless shown otherwise. Fiscal quarters.

Silicon Laboratories Inc.: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Apr 2025	2025 Q2Jul 2025	2025 Q3Oct 2025	2025 Q4Jan 2026	2026 Q1Apr 2026	2026 Q2Jul 2026
Receivables	49	54	52	56	67	65	77	80
Inventory	139	106	83	81	82	96	103	123
Total current assets	614	602	619	618	653	674	676	671
Goodwill	376	376	376	376	376	376	376	376
Total assets	1,249	1,223	1,229	1,221	1,253	1,269	1,266	1,253
Accounts payable	45	42	54	58	56	51	56	52
Total current liabilities	118	98	120	121	145	144	132	124
Total liabilities	168	143	161	160	182	175	168	158
Shareholders' equity	1,081	1,080	1,068	1,061	1,071	1,094	1,099	1,095
Shares outstanding	32m	32m	32m	33m	33m	33m	33m	33m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: PLAB vs SLAB HIMX vs SLAB SIMO vs SLAB FORM vs SLAB

More: Semiconductors stocks compared, Technology sector, rankings of US companies

Figures from Silicon Laboratories Inc.'s SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Silicon Laboratories Inc.